ASX - By Stock
|
OSL |
Re:
Ann: Letter to Short Dated Option Holders
|
|
80/20
|
57 |
19K |
0 |
18/07/24 |
18/07/24 |
ASX - By Stock
|
57
|
19K
|
0
|
|
ASX - By Stock
|
LTM |
Re:
General Discussion
|
|
80/20
|
2.4K |
1.1M |
7 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
2.4K
|
1.1M
|
7
|
|
ASX - By Stock
|
OSL |
Re:
Ann: First patient treated in the UK for the TRIPP-FXX study
|
|
80/20
|
19 |
5.6K |
2 |
13/04/24 |
13/04/24 |
ASX - By Stock
|
19
|
5.6K
|
2
|
|
ASX - By Stock
|
OSL |
Re:
News: OSL Oncosil Medical Seeks Trading Halt
|
|
80/20
|
58 |
15K |
1 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
58
|
15K
|
1
|
|
ASX - By Stock
|
PLS |
Re:
Lithium Supply and Demand
|
|
80/20
|
199 |
103K |
6 |
05/02/24 |
05/02/24 |
ASX - By Stock
|
199
|
103K
|
6
|
|
ASX - By Stock
|
OSL |
Re:
Ann: 84 German hospitals can negotiate fee for Oncosil device
|
|
80/20
|
39 |
11K |
0 |
03/02/24 |
03/02/24 |
ASX - By Stock
|
39
|
11K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: 84 German hospitals can negotiate fee for Oncosil device
|
|
80/20
|
39 |
11K |
0 |
01/02/24 |
01/02/24 |
ASX - By Stock
|
39
|
11K
|
0
|
|
ASX - By Stock
|
LTM |
Re:
General Discussion
|
|
80/20
|
2.4K |
1.1M |
0 |
22/01/24 |
22/01/24 |
ASX - By Stock
|
2.4K
|
1.1M
|
0
|
|
ASX - By Stock
|
LTM |
Re:
General Discussion
|
|
80/20
|
2.4K |
1.1M |
1 |
17/01/24 |
17/01/24 |
ASX - By Stock
|
2.4K
|
1.1M
|
1
|
|
ASX - By Stock
|
PLS |
Re:
Good News & Bad News
|
|
80/20
|
46K |
23M |
2 |
11/01/24 |
11/01/24 |
ASX - By Stock
|
46K
|
23M
|
2
|
|
ASX - By Stock
|
LTM |
Re:
General Discussion
|
|
80/20
|
2.4K |
1.1M |
11 |
10/01/24 |
10/01/24 |
ASX - By Stock
|
2.4K
|
1.1M
|
11
|
|
ASX - By Stock
|
LTM |
Re:
General Discussion
|
|
80/20
|
2.4K |
1.1M |
0 |
05/01/24 |
05/01/24 |
ASX - By Stock
|
2.4K
|
1.1M
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Pancreatic Cancer in the Media
|
|
80/20
|
62 |
18K |
1 |
08/12/23 |
08/12/23 |
ASX - By Stock
|
62
|
18K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
Ann: First two commercial patient treatments in Greece
|
|
80/20
|
4 |
2.1K |
1 |
08/12/23 |
08/12/23 |
ASX - By Stock
|
4
|
2.1K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
Ann: OncoSil onboards first patient in PANCOSIL Clinical Trial
|
|
80/20
|
19 |
5.7K |
1 |
29/11/23 |
29/11/23 |
ASX - By Stock
|
19
|
5.7K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
80/20
|
65 |
18K |
1 |
03/11/23 |
03/11/23 |
ASX - By Stock
|
65
|
18K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
Pancreatic Cancer in the Media
|
|
80/20
|
62 |
18K |
0 |
30/10/23 |
30/10/23 |
ASX - By Stock
|
62
|
18K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Entitlement Offer Results and Shortfall Notification
|
|
80/20
|
133 |
42K |
2 |
17/05/23 |
17/05/23 |
ASX - By Stock
|
133
|
42K
|
2
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Entitlement Offer Results and Shortfall Notification
|
|
80/20
|
133 |
42K |
0 |
16/05/23 |
16/05/23 |
ASX - By Stock
|
133
|
42K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Entitlement Offer Results and Shortfall Notification
|
|
80/20
|
133 |
42K |
0 |
15/05/23 |
15/05/23 |
ASX - By Stock
|
133
|
42K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Two key treatment centres treat first patients with OncoSil
|
|
80/20
|
23 |
10K |
1 |
06/02/23 |
06/02/23 |
ASX - By Stock
|
23
|
10K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Two key treatment centres treat first patients with OncoSil
|
|
80/20
|
23 |
10K |
0 |
03/02/23 |
03/02/23 |
ASX - By Stock
|
23
|
10K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Bupa UK Approves Reimbursement for OncoSil in the UK
|
|
80/20
|
42 |
18K |
0 |
09/07/22 |
09/07/22 |
ASX - By Stock
|
42
|
18K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Investor Presentation
|
|
80/20
|
11 |
8.2K |
0 |
17/06/22 |
17/06/22 |
ASX - By Stock
|
11
|
8.2K
|
0
|
|
ASX - By Stock
|
NAB |
Re:
NAB - UNABLE TO MEET DEADLINE FOR CLOUD PROJECT BUSINESS BANKING
|
|
80/20
|
23 |
9.3K |
0 |
09/06/22 |
09/06/22 |
ASX - By Stock
|
23
|
9.3K
|
0
|
|
ASX - By Stock
|
NAB |
Re:
NAB - UNABLE TO MEET DEADLINE FOR CLOUD PROJECT BUSINESS BANKING
|
|
80/20
|
23 |
9.3K |
1 |
09/06/22 |
09/06/22 |
ASX - By Stock
|
23
|
9.3K
|
1
|
|
ASX - By Stock
|
FLT |
Re:
$30 FLT PARTY
|
|
80/20
|
300 |
172K |
1 |
17/04/22 |
17/04/22 |
ASX - By Stock
|
300
|
172K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Fully-Funded Trial Approved In Germany
|
|
80/20
|
21 |
13K |
1 |
02/04/22 |
02/04/22 |
ASX - By Stock
|
21
|
13K
|
1
|
|
ASX - By Stock
|
SUN |
Re:
Queensland Floods
|
|
80/20
|
22 |
11K |
1 |
12/03/22 |
12/03/22 |
ASX - By Stock
|
22
|
11K
|
1
|
|
ASX - By Stock
|
A2M |
Re:
Empty A2M formula shelves. Please report you local supermarket stock levels
|
|
80/20
|
179 |
89K |
13 |
04/01/22 |
04/01/22 |
ASX - By Stock
|
179
|
89K
|
13
|
|
ASX - By Stock
|
OSL |
Re:
This sounds familiar.....AllVascular ?
|
|
80/20
|
3 |
3.1K |
0 |
15/12/21 |
15/12/21 |
ASX - By Stock
|
3
|
3.1K
|
0
|
|
ASX - By Stock
|
LYC |
Re:
Lynas and Afghanistan
|
|
80/20
|
42 |
16K |
1 |
27/08/21 |
27/08/21 |
ASX - By Stock
|
42
|
16K
|
1
|
|
ASX - By Stock
|
A2M |
Annual Report Leaked ?
|
|
80/20
|
18 |
7.0K |
2 |
26/07/21 |
26/07/21 |
ASX - By Stock
|
18
|
7.0K
|
2
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Otto Buttula appointed to the Board of OncoSil
|
|
80/20
|
20 |
13K |
0 |
22/07/21 |
22/07/21 |
ASX - By Stock
|
20
|
13K
|
0
|
|
ASX - By Stock
|
A2M |
Re:
FDA approval for infant formula
|
|
80/20
|
2 |
1.3K |
3 |
19/06/21 |
19/06/21 |
ASX - By Stock
|
2
|
1.3K
|
3
|
|
ASX - By Stock
|
OSL |
Any progress in marketing in UK?
|
|
80/20
|
12 |
7.1K |
0 |
18/06/21 |
18/06/21 |
ASX - By Stock
|
12
|
7.1K
|
0
|
|
ASX - By Stock
|
A2M |
Re:
Media Updates
|
|
80/20
|
14K |
7.3M |
1 |
29/05/21 |
29/05/21 |
ASX - By Stock
|
14K
|
7.3M
|
1
|
|
ASX - By Stock
|
SPT |
Re:
Watch This Space
|
|
80/20
|
8.0K |
2.6M |
1 |
28/05/21 |
28/05/21 |
ASX - By Stock
|
8.0K
|
2.6M
|
1
|
|
ASX - By Stock
|
A2M |
Takeover Speculation
|
|
80/20
|
419 |
181K |
3 |
19/05/21 |
19/05/21 |
ASX - By Stock
|
419
|
181K
|
3
|
|
ASX - By Stock
|
A2M |
Re:
Media Updates
|
|
80/20
|
14K |
7.3M |
2 |
19/05/21 |
19/05/21 |
ASX - By Stock
|
14K
|
7.3M
|
2
|
|
ASX - By Stock
|
A2M |
Re:
A2M Strategic Valuation
|
|
80/20
|
92 |
40K |
0 |
18/05/21 |
18/05/21 |
ASX - By Stock
|
92
|
40K
|
0
|
|
ASX - By Stock
|
A2M |
Re:
Media Updates
|
|
80/20
|
14K |
7.3M |
0 |
09/05/21 |
09/05/21 |
ASX - By Stock
|
14K
|
7.3M
|
0
|
|
ASX - By Stock
|
A2M |
Re:
DON'T PANIC A2 HOLDERS, YOU ARE IN A BETTER SPOT THAN MOST
|
|
80/20
|
402 |
133K |
4 |
15/03/21 |
15/03/21 |
ASX - By Stock
|
402
|
133K
|
4
|
|
ASX - By Stock
|
A2M |
Re:
DON'T PANIC A2 HOLDERS, YOU ARE IN A BETTER SPOT THAN MOST
|
|
80/20
|
402 |
133K |
0 |
14/03/21 |
14/03/21 |
ASX - By Stock
|
402
|
133K
|
0
|
|
ASX - By Stock
|
SPT |
Watch a new space?
|
|
80/20
|
7 |
3.2K |
0 |
09/03/21 |
09/03/21 |
ASX - By Stock
|
7
|
3.2K
|
0
|
|
ASX - By Stock
|
A2M |
Re:
DON'T PANIC A2 HOLDERS, YOU ARE IN A BETTER SPOT THAN MOST
|
|
80/20
|
402 |
133K |
0 |
02/03/21 |
02/03/21 |
ASX - By Stock
|
402
|
133K
|
0
|
|
ASX - By Stock
|
A2M |
Re:
Chart Update
|
|
80/20
|
25K |
13M |
1 |
26/02/21 |
26/02/21 |
ASX - By Stock
|
25K
|
13M
|
1
|
|
ASX - By Stock
|
A2M |
Re:
Earnings day
|
|
80/20
|
100 |
37K |
1 |
25/02/21 |
25/02/21 |
ASX - By Stock
|
100
|
37K
|
1
|
|
ASX - By Stock
|
A2M |
Re:
Chart Update
|
|
80/20
|
25K |
13M |
2 |
23/02/21 |
23/02/21 |
ASX - By Stock
|
25K
|
13M
|
2
|
|
ASX - By Stock
|
CIM |
Re:
Ann: FY20 STATUTORY NPAT $620M, REVENUE $11.4B, NET CASH $190M
|
|
80/20
|
37 |
18K |
0 |
11/02/21 |
11/02/21 |
ASX - By Stock
|
37
|
18K
|
0
|
|